News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
News 13 dez 2023 Macrogen establishes foothold in Basel Macrogen Europe is set to move into the Novartis Campus of Switzerland Innovation Park Basel Area. As with its parent company, the South Korean b...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon 23 abr 2024 10:15–12:10 Zürich Suíça
News 30 jan 2024 Top Stories from Western Switzerland (January 2024) From groundbreaking advancements in agrifood and robotics to strategic economic reforms and pioneering research in space and medicine, discover W...
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan 23 abr 2024 10:15–12:10 Zürich Suíça
Member of the Month 03 fev 2023 BROMATECH Suisse SA: "S-GE helps us better understand sales markets as well as the distribution channels" BROMATECH Switzerland is active in the development of dietary supplements based on lactic acid bacteria capable of interacting in a targeted and ...
Evento S-GE Fattori chiave di successo per fare affari in Giappone 23 abr 2024 10:15–12:10 Zürich Suíça
News 26 jan 2022 Basel Area – exactly the right chemistry for South Korean pharma companies KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the Europe...
News 19 out 2023 Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment Biel-based Mimix Biotherapeutics announced the closure of a significant investment round, drawing participation from both European and Asian inve...